Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands

PURPOSE: Patient management of invasive breast cancer (IBC) is to a large extent based on hormone- and HER2-receptor assessment. High-quality, reliable receptor assessment is of key importance as false results may lead to under- or overtreatment of patients. Surveillance of case-mix adjusted positiv...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dooijeweert, Carmen, Deckers, Ivette A. G., Baas, Inge O., van der Wall, Elsken, van Diest, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533417/
https://www.ncbi.nlm.nih.gov/pubmed/30825048
http://dx.doi.org/10.1007/s10549-019-05180-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533417/
https://www.ncbi.nlm.nih.gov/pubmed/30825048
http://dx.doi.org/10.1007/s10549-019-05180-5

Ejemplares similares